+86 189 1304 2753 product@eynoslifescience.com

Mouse liver from 8 animals, enzymatically dissociated into a single-cell suspension: 8×10⁶ cells in total. After column-based positive selection, 87.02% of live cells were CD45⁺CD19⁺. The cells were then plated and activated with anti-IgM plus anti-CD40.

Liver is not a lymphoid organ in the usual sense, and the B cells it contains differ from splenic B cells in both number and subset composition. The practical consequences showed up in this run: the starting cell count was low, the CD19 signal appeared weaker, and a visible fraction of CD19⁺ cells stayed in the flow-through. All three are worth planning for.

Key points

Gating chain after selection

GateDefinitionShare
P1FSC-A × SSC-A, debris excluded96.27%
P2FSC-A × FSC-H, singlets89.36%
P3SSC-A × zombie KO525-A, live cells91.26%
P4CD45-APC-A750 × CD19-FITC87.02% CD45⁺CD19⁺

Products used in this work

This page is the English summary. The full bench-level article covers why hepatic B cells behave differently, the three practical notes from the customer (low cell yield, weaker CD19 and flow-through recovery, lower viability after activation), a side-by-side with the spleen validation, and the limits of this dataset: read the full article (Chinese).

Questions about this protocol?

Tell us your sample type (whole blood or PBMC), the volume you start from and the downstream assay — we will suggest a separation route, a column and the matching catalogue numbers.